// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Clinical utility of molecular profiling using EUS-guided Biopsies in Pancreatic cancer: The PRECISION-Panc experience

S. Dreyer - International Hepato-Pancreato-Biliary Association (IHPBA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Pancreatic cancer

N/A

Could strategies to control local disease recurrence after resection of pancreatic cancer improve outcome?

M. Kalisvaart - International Hepato-Pancreato-Biliary Association (IHPBA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Pancreatic cancer

N/A

Portal or hepatic Vein reconstruction at stage I of ALPPS - how far can we push the boundaries?

A. Schlegel - International Hepato-Pancreato-Biliary Association (IHPBA) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Early repair of major bile duct injury by specialist surgeons leads to superior long-term outcomes and reduced costs of treatment and litigation

J. Halle-Smith - International Hepato-Pancreato-Biliary Association (IHPBA) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Indications for open left lateral sectionectomy in the Era of laparoscopic liver surgery

A. Chan - International Hepato-Pancreato-Biliary Association (IHPBA) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Liver resection for colorectal hepatic metastases after systemic chemotherapy and selective internal radiation therapy with Yttrium-90 Microspheres (SIRT): the current world experience

M. Baltatzis - International Hepato-Pancreato-Biliary Association (IHPBA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal liver metastases

N/A

Factors predicting disease progression following percutaneous microwave ablation of colorectal liver metastasis: evidence for the heat sink effect

T. Urbonas - International Hepato-Pancreato-Biliary Association (IHPBA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal liver metastases

N/A

Oncological outcomes of portal vein embolisation followed by major liver resection: a 6-year experience

E. Martinou - International Hepato-Pancreato-Biliary Association (IHPBA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal liver metastases

N/A

Radio-frequency ablation for treatment of NET liver metastases: assessment of utilisation at a single tertiary centre

A. Tan - International Hepato-Pancreato-Biliary Association (IHPBA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Secondary liver cancer

N/A

Laparoscopic versus open repeat liver resection for colorectal liver metastases: a multicenter propensity score matched study

M.J. van der Poel - International Hepato-Pancreato-Biliary Association (IHPBA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal liver metastases

N/A

Impact of resection margin and histological growth pattern at resection for colorectal liver metastasis: a pilot study

J. Helliwell - International Hepato-Pancreato-Biliary Association (IHPBA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal liver metastases

N/A

Preoperative leukocytes-based inflammatory scores in patients with colorectal liver metastases: can we count on them?

A. Dupr - International Hepato-Pancreato-Biliary Association (IHPBA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal liver metastases

N/A

Perioperative immunonutrition in major hepatic resection: a systematic review and meta-analysis

C.S. Wong - International Hepato-Pancreato-Biliary Association (IHPBA) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Laparoscopic liver resection for large HCC: short and long term outcomes in relation to tumor size

G.B. Levi Sandri - International Hepato-Pancreato-Biliary Association (IHPBA) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Functional synergy of CCAAT/enhancer-binding protein alpha and beta promotes anti-proliferative effect in HCC

X. Zhao - International Hepato-Pancreato-Biliary Association (IHPBA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Liver cancer

Camphor and menthol topical

Predictors of survival following trans-arterial chemoembolization for the palliative treatment of hepatocellular carcinoma

M. Hughes - International Hepato-Pancreato-Biliary Association (IHPBA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Liver cancer

N/A

Early derangement of the international normalized ratio (INR) predicts liver insufficiency following liver resection for hepatocellular carcinoma

A.N. Silva - International Hepato-Pancreato-Biliary Association (IHPBA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Liver cancer

N/A

Liver resection for ruptured hepatocellular carcinoma – A propensity matched analysis

N. Pinsker - International Hepato-Pancreato-Biliary Association (IHPBA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Liver cancer

N/A

Towards zero mortality in elective liver surgery

S. Jegatheeswaran - International Hepato-Pancreato-Biliary Association (IHPBA) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Laparoscopic vs open hepatectomy for hepatocellular carcinoma in patients with cirrhosis: a meta-analysis of the long-term survival outcomes

E.L. Goh - International Hepato-Pancreato-Biliary Association (IHPBA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Liver cancer

N/A

Copyright © 2026. QuantiNova All rights reserved